1. Cui Bono?

   • Michael Ashby
   • Bronwen Morrell

   Editorial 26 May 2020 Pages: 1 - 3

2. The Consent Form in the Chinese CRISPR Study: In Search of Ethical Gene Editing

   • David Shaw

   Guest Editorial 03 January 2020 Pages: 5 - 10

3. A Continent Aflame: Ethical Lessons From the Australian Bushfire Disaster

   • Paul Komesaroff
   • Ian Kerridge

   Editorial 09 March 2020 Pages: 11 - 14

4. Balancing Interests in Healthcare

   • Bernadette Richards

   Recent Developments 15 May 2020 Pages: 15 - 20

5. A Response to “Fragile Objects”

   • Paul Macneill

   Critical Response 30 December 2019 Pages: 21 - 23

6. Lead Essay: Money, Equity and Access to Medicines

   • Narcyz Ghinea
   • Wendy Lipworth
   • Ian Kerridge

   Symposium: Pharmaceutical Ethics 02 March 2020 Pages: 25 - 27

7. Why High Drug Pricing Is A Problem for Research Ethics

   • Spencer Phillips Hey

   Symposium: Pharmaceutical Ethics 19 December 2019 Pages: 29 - 35

8. “Hunting Down My Son’s Killer”: New Roles of Patients in Treatment Discovery and Ethical Uncertainty

   • Marcello Ienca
   • Effy Vayena

   Symposium: Pharmaceutical Ethics 26 February 2020 Pages: 37 - 47

9. Pharmaceutical Ethics and Grassroots Activism in the United States: A Social History Perspective

   • Sharon Batt
   • Judy Butler
   • Adriane Fugh-Berman

   Symposium: Pharmaceutical Ethics 17 January 2020 Pages: 49 - 60

10. Commentary: The Voice of the People, Funded Now by Your Friendly Pharmaceutical Company

    • Ray Moynihan

    Symposium: Pharmaceutical Ethics 24 March 2020 Pages: 61 - 63

11. Developing and Implementing new TB Technologies: Key Informants’ Perspectives on the Ethical Challenges

    • Renaud F. Boulanger
    • Ana Komparic
    • Diego S. Silva

    Symposium: Pharmaceutical Ethics 19 December 2019 Pages: 65 - 73

12. Formulating an Ethics of Pharmaceutical Disinvestment

    • Jessica Pace
    • Tracey-Lea Laba
    • Wendy Lipworth

    Symposium: Pharmaceutical Ethics 04 March 2020 Pages: 75 - 86

13. Does Consumer Engagement in Health Technology Assessment Enhance or Undermine Equity?

    • Narcyz Ghinea
    • Wendy Lipworth
    • Ian Kerridge

    Symposium: Pharmaceutical Ethics 14 February 2020 Pages: 87 - 94

14. Pure Altruistic Gift and the Ethics of Transplant Medicine

    • Paweł Łuków

    Original Research Open access 10 December 2019 Pages: 95 - 107

15. Deciding For When You Can’t Decide: The Medical Treatment Planning and Decisions Act 2016 (Vic)

    • Courtney Hempton
    • Neera Bhatia

    Original Research 13 February 2020 Pages: 109 - 120

16. New Zealand Policy on Frozen Embryo Disputes

    • Carolyn Mason

    Original Research 10 February 2020 Pages: 121 - 131

17. Beyond Mendelian Genetics: Anticipatory Biomedical Ethics and Policy Implications for the Use of CRISPR Together with Gene Drive in Humans

    • Michael W. Nestor
    • Richard L. Wilson

    Original Research 03 January 2020 Pages: 133 - 144

    

18. Elective Impairment Minus Elective Disability: The Social Model of Disability and Body Integrity Identity Disorder

    • Richard B. Gibson

    Original Research Open access 19 December 2019 Pages: 145 - 155